- Home
- BIAF vs XTIA Comparison
BIAF vs XTIA Comparison
Compare BIAF & XTIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- XTIA
- Stock Information
- Founded
- BIAF 2014
- XTIA 1999
- Country
- BIAF United States
- XTIA United States
- Employees
- BIAF N/A
- XTIA N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- XTIA
- Sector
- BIAF Health Care
- XTIA
- Exchange
- BIAF Nasdaq
- XTIA NYSE
- Market Cap
- BIAF 12.2M
- XTIA 10.6M
- IPO Year
- BIAF 2022
- XTIA N/A
- Fundamental
- Price
- BIAF $0.30
- XTIA $1.71
- Analyst Decision
- BIAF Hold
- XTIA
- Analyst Count
- BIAF 1
- XTIA 0
- Target Price
- BIAF N/A
- XTIA N/A
- AVG Volume (30 Days)
- BIAF 11.2M
- XTIA 7.5M
- Earning Date
- BIAF 08-13-2025
- XTIA 08-13-2025
- Dividend Yield
- BIAF N/A
- XTIA N/A
- EPS Growth
- BIAF N/A
- XTIA N/A
- EPS
- BIAF N/A
- XTIA N/A
- Revenue
- BIAF $8,809,228.00
- XTIA $3,466,000.00
- Revenue This Year
- BIAF N/A
- XTIA $59.74
- Revenue Next Year
- BIAF $20.00
- XTIA N/A
- P/E Ratio
- BIAF N/A
- XTIA N/A
- Revenue Growth
- BIAF 78.40
- XTIA 1475.45
- 52 Week Low
- BIAF $0.16
- XTIA $0.96
- 52 Week High
- BIAF $2.99
- XTIA $187.50
- Technical
- Relative Strength Index (RSI)
- BIAF 50.96
- XTIA 42.61
- Support Level
- BIAF $0.22
- XTIA $2.63
- Resistance Level
- BIAF $0.46
- XTIA $4.22
- Average True Range (ATR)
- BIAF 0.04
- XTIA 0.88
- MACD
- BIAF 0.01
- XTIA -0.23
- Stochastic Oscillator
- BIAF 30.51
- XTIA 0.69
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About XTIA XTI AEROSPACE
XTI Aerospace Inc is an aircraft development company. It also provides real-time location systems (RTLS) for the industrial sector. The company is developing a vertical takeoff and landing (VTOL) airplane that is designed to take off and land like a helicopter and cruise like a fixed-wing business airplane. Its initial configuration, the TriFan 600 airplane, will be one of the first civilian fixed-wing VTOL airplane that offers the speed and comfort of a business airplane and the range and versatility of VTOL for a wide range of customer applications, including private aviation for business and high net worth individuals, emergency medical services, and regional charter air travel. The company operates in two reportable segments: Industrial IoT and Commercial Aviation.